Back



Edgen - healthcare : pharma



Search

EN

healthcare: pharmaNews

For you Markets Economy Tech & AI Crypto Energy Healthcare HK & China Finance

Pharma

Biotech

Health Services

Medical Devices

Novo Nordisk's Wegovy wins UK nod for heart risk reduction in 20% of patients

Novo Nordisk's Wegovy wins UK nod for heart risk reduction in 20% of patients

Mar 31 2026, 23:25

ORIC Pharma selects Rinzimetostat dose for Phase 3 cancer trial starting in 1H 2026

ORIC Pharma selects Rinzimetostat dose for Phase 3 cancer trial starting in 1H 2026

Mar 31 2026, 20:25

Eli Lilly to buy Centessa for $6.3B, boosting neuroscience assets

Eli Lilly to buy Centessa for $6.3B, boosting neuroscience assets

Mar 31 2026, 16:03

FDA Warns of Liver Injury Risk With Amgen's Autoimmune Drug

FDA Warns of Liver Injury Risk With Amgen's Autoimmune Drug

Mar 31 2026, 15:36

Corning Jerry and CSPC drug KN026 succeeds in Phase 3 breast cancer trial

Corning Jerry and CSPC drug KN026 succeeds in Phase 3 breast cancer trial

Mar 31 2026, 15:02

Jacobio Pharma 2025 loss widens to RMB 296 million

Jacobio Pharma 2025 loss widens to RMB 296 million

Mar 31 2026, 14:17

Hoth Therapeutics Jumps 8% After Securing China Patent for Cancer Therapy

Hoth Therapeutics Jumps 8% After Securing China Patent for Cancer Therapy

Mar 31 2026, 12:21

Novo Nordisk offers Wegovy subscriptions with up to 29% discount

Novo Nordisk offers Wegovy subscriptions with up to 29% discount

Mar 31 2026, 11:55

Poxel to receive up to $196 million from Scynexis for kidney disease drug

Poxel to receive up to $196 million from Scynexis for kidney disease drug

Mar 31 2026, 11:26

Agios seeks accelerated FDA nod for mitapivat after 207-patient trial

Agios seeks accelerated FDA nod for mitapivat after 207-patient trial

Mar 31 2026, 11:26

Guardian Pharmacy stock jumps 9.1% on unusual volume

Guardian Pharmacy stock jumps 9.1% on unusual volume

Mar 31 2026, 11:16

Poolbeg Pharma stock jumps 10% on Australian patent news

Poolbeg Pharma stock jumps 10% on Australian patent news

Mar 31 2026, 11:00

Oculis Gains 8% After EMA Grants PRIME Status to Eye Drug

Oculis Gains 8% After EMA Grants PRIME Status to Eye Drug

Mar 31 2026, 08:58

United Therapeutics Jumps 13% as Tyvaso Succeeds in Lung Trial

United Therapeutics Jumps 13% as Tyvaso Succeeds in Lung Trial

Mar 31 2026, 08:30

no more news

Features

AI Copilot for Stock & Crypto

Price Prediction

Fundraise Tracker

Crypto Comparison

Resources

Market

Terms of Use Privacy Policy Sitemap

© 2026 Finture Development Limited. All rights reserved